fullPIERS - Adverse Maternal Outcome Risk
ورودیهای بالینی بیمار
حداقل ۲۰ — حداکثر ۴۴ • واحد: weeks
حداقل ۲۰ — حداکثر ۱۵۰۰ • واحد: umol/L
حداقل ۱۰ — حداکثر ۱۰۰۰ • واحد: x10^9/L
حداقل ۵ — حداکثر ۱۰۰۰۰ • واحد: U/L
حداقل ۵۰ — حداکثر ۱۰۰ • واحد: %
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- calculated≥ 0
The fullPIERS - Adverse Maternal Outcome Risk calculates calculating gestational age, evaluating maternal-fetal wellbeing, and assessing perinatal complications. Key inputs include gestational age weeks. Scores guide determining delivery timing, administering antenatal corticosteroids or tocolytics, and obstetric monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Preeclampsia integrated estimate of risk (logistic model) within 48h.
Clinical Indication
The fullPIERS - Adverse Maternal Outcome Risk is indicated for bedside clinical practice to support Preeclampsia integrated estimate of risk (logistic model) within 48h.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Pregnant individuals across antepartum, intrapartum, and postpartum stages, or patients with acute gynecologic conditions. Clinical application is indicated across Labor and delivery suites, obstetric triage, antenatal clinics, and gynecologic surgical units.
Limitations & Contraindications
Normal gestational physiological adaptations alter baseline plasma volume, serum creatinine, and resting heart rate.
Clinical Pearls & Action Plan
Simultaneous surveillance of maternal hemodynamic stability and continuous electronic fetal heart rate monitoring is paramount.
logit = 2.68 -0.0541xGA +1.23x(chest pain/dyspnea) -0.0271xcreat +0.207xplt +0.00004xplt^2 +0.0101xAST -0.00000305xAST^2 +0.00025xcreatxplt -0.0000699xpltxAST -0.00256xpltxSpO2; p=1/(1+e^-logit)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| gestational_age_weeks | float | Yes | Gestational age at eligibility(weeks) |
| creatinine_umol_l | float | Yes | Serum creatinine(umol/L) |
| platelets_x1e9_l | float | Yes | Platelets(x10^9/L) |
| ast_u_l | float | Yes | AST(U/L) |
| spo2_percent | float | Yes | SpO2(%) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≥ 0 | calculated | Calculated value |
Evidence-Based References (EBM)
- von Dadelszen P, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011;377(9761):219-227.